We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTN icon
1426
Gray Television
GTN
$552M
$13.1M 0.01%
611,354
-79,749
-12% -$1.48M
SC
1427
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$13.1M 0.01%
560,342
-499,073
-47% -$12.1M
ENS icon
1428
EnerSys
ENS
$6.99B
$13.1M 0.01%
174,616
-6,315
-3% -$437K
STL
1429
DELISTED
Sterling Bancorp
STL
$13M ﹤0.01%
617,841
+3,952
+0.6% +$80.6K
SYKE
1430
DELISTED
SYKES Enterprises Inc
SYKE
$13M ﹤0.01%
351,262
+25,515
+8% +$862K
AWR icon
1431
American States Water
AWR
$3.46B
$13M ﹤0.01%
149,794
-2,528
-2% -$224K
DEA
1432
Easterly Government Properties
DEA
$1.18B
$13M ﹤0.01%
218,758
-41,231
-16% -$2.33M
CTRE icon
1433
CareTrust REIT
CTRE
$9.74B
$12.9M ﹤0.01%
626,904
-955,481
-60% -$20.9M
RARE icon
1434
Ultragenyx Pharmaceutical
RARE
$2.55B
$12.9M ﹤0.01%
302,769
+29,383
+11% +$1.21M
VRNS icon
1435
Varonis Systems
VRNS
$5B
$12.9M ﹤0.01%
499,092
-36,702
-7% -$872K
MUR icon
1436
Murphy Oil
MUR
$4.78B
$12.9M ﹤0.01%
481,333
+139,384
+41% +$3.2M
COHR
1437
DELISTED
Coherent Inc
COHR
$12.9M ﹤0.01%
77,499
-1,855
-2% -$287K
ROG icon
1438
Rogers Corp
ROG
$2.4B
$12.9M ﹤0.01%
103,146
-1,092
-1% -$148K
MTOR
1439
DELISTED
MERITOR, Inc.
MTOR
$12.8M ﹤0.01%
487,934
-166,140
-25% -$3.75M
AVYA
1440
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$12.7M ﹤0.01%
941,313
+411,229
+78% +$5.05M
EBS icon
1441
Emergent Biosolutions
EBS
$248M
$12.7M ﹤0.01%
235,315
+47,912
+26% +$2.6M
ZTO icon
1442
ZTO Express
ZTO
$17.9B
$12.7M ﹤0.01%
542,100
-89,200
-14% -$1.93M
GLNG icon
1443
Golar LNG
GLNG
$5.13B
$12.7M ﹤0.01%
889,594
-369,410
-29% -$5.01M
ABCB icon
1444
Ameris Bancorp
ABCB
$5.89B
$12.6M ﹤0.01%
297,081
-129,774
-30% -$5.54M
HSII
1445
DELISTED
Heidrick & Struggles
HSII
$12.6M ﹤0.01%
387,731
-4,226
-1% -$124K
CNOB icon
1446
Center Bancorp
CNOB
$1.78B
$12.5M ﹤0.01%
487,601
-25,367
-5% -$618K
CVBF icon
1447
CVB Financial
CVBF
$3.99B
$12.5M ﹤0.01%
579,202
+61,033
+12% +$1.29M
GHC icon
1448
Graham Holdings Company
GHC
$5.02B
$12.5M ﹤0.01%
19,561
-1,202
-6% -$769K
ADNT icon
1449
Adient
ADNT
$1.5B
$12.5M ﹤0.01%
587,093
+239,188
+69% +$5.31M
LECO icon
1450
Lincoln Electric
LECO
$15.4B
$12.5M ﹤0.01%
128,871
-7,107
-5% -$647K

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.